IL15 and rheumatoid arthritis: In a proof-of-concept study in rheumatoid arthritis patients, the use of human IgG1 anti-IL-15 monoclonal antibody (HuMaxIL15) showed suitable drug tolerability with no significant effects on T lymphocyte subset and NK cell numbers.